Author

Philip C. Hill

McAuley Professor of International Health, University of Otago - Cited by 14,702 - International Health - Epidemiology - Epidemiomics - Infectious Diseases

Biography

Professor Philip Hill holds separate qualifications as a medical practitioner (MBChB), specialist public health physician (MPH; FAFPHM; FNZCPHM), specialist infectious diseases physician (FRACP), as well as a doctorate in the epidemiology of tuberculosis in The Gambia (MD). After completing specialty training in New Zealand, he spent 6 years working as a clinical epidemiologist at the Medical Research Council (UK) research unit in The Gambia, working on tuberculosis (TB) and pneumonia projects.
Title
Cited by
Year
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis
L Martinez, O Cords, Q Liu, C Acuna-Villaorduna, M Bonnet, GJ Fox, ...The Lancet Global Health 10 (9), e1307-e1316, 2022202
34
2022
Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia
BW Lestari, S McAllister, PF Hadisoemarto, N Afifah, ID Jani, M Murray, ...The Lancet Regional Health–Western Pacific 5, 2020202
34
2020
BCG‐induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next‐generation vaccines
M Foster, PC Hill, TP Setiabudiawan, VACM Koeken, B Alisjahbana, ...Immunological reviews 301 (1), 122-144, 2021202
29
2021
A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatment
P Khadka, PC Hill, B Zhang, R Katare, J Dummer, SC DasInternational Journal of Pharmaceutics 587, 119602, 2020202
21
2020
Defining covid-19 elimination
DCG Skegg, PC Hillbmj 374, 2021202
18
2021
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial
O Oxlade, A Benedetti, M Adjobimey, H Alsdurf, S Anagonou, VJ Cook, ...The Lancet Public Health 6 (5), e272-e282, 2021202
17
2021
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance
GA Mackenzie, PC Hill, DJ Jeffries, M Ndiaye, SM Sahito, I Hossain, ...The Lancet Infectious Diseases 21 (9), 1293-1302, 2021202
15
2021
Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats
P Khadka, S Sinha, IG Tucker, J Dummer, PC Hill, R Katare, SC DasEuropean Journal of Pharmaceutics and Biopharmaceutics 162, 1-11, 2021202
12
2021
A public health approach to increase treatment of latent TB among household contacts in Brazil
ML Bastos, O Oxlade, A Benedetti, F Fregonese, C Valiquette, SCC Lira, ...The International Journal of Tuberculosis and Lung Disease 24 (10), 1000-100, 2020202
8
2020
Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar
HL Aung, WW Nyunt, Y Fong, PJ Biggs, RC Winkworth, PJ Lockhart, ...Emerging infectious diseases 27 (11), 247, 2021202
8
2021
Screening diabetes mellitus patients for pulmonary tuberculosis: a multisite study in Indonesia, Peru, Romania and South Africa
B Alisjahbana, SM McAllister, C Ugarte-Gil, NM Panduru, K Ronacher, ...Transactions of the Royal Society of Tropical Medicine and Hygiene 115 ( …, 2021202
6
2021
Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding
B Alisjahbana, RC Koesoemadinata, PF Hadisoemarto, BW Lestari, ...Plos one 1 (8), e025043, 2021202
6
2021
The effect of a structured clinical algorithm on glycemic control in patients with combined tuberculosis and diabetes in Indonesia: A randomized trial
R Ruslami, RC Koesoemadinata, NNM Soetedjo, S Imaculata, ...Diabetes Research and Clinical Practice 173, 108701, 2021202
6
2021
Studies on the safety and the tissue distribution of inhaled high-dose amorphous and crystalline rifampicin in a rat model
P Khadka, S Sinha, IG Tucker, J Dummer, PC Hill, R Katare, SC DasInternational Journal of Pharmaceutics 597, 12035, 2021202
4
2021
Cost analysis and critical success factors of the use of oxygen concentrators versus cylinders in sub-divisional hospitals in Fiji
S McAllister, L Thorn, S Boladuadua, M Gil, R Audas, T Edmonds, E Rafai, ...BMC health services research 21 (1), 1-7, 2021202
4
2021
Healthcare Seeking and Access to Care for Pneumonia, Sepsis, Meningitis, and Malaria in Rural Gambia
I Hossain, P Hill, C Bottomley, M Jasseh, K Bojang, M Kaira, A Sankareh, ...The American journal of tropical medicine and hygiene 106 (2), 6, 2022202
4
2022
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection
M Musvosvi, H Huang, C Wang, Q Xia, V Rozot, A Krishnan, P Acs, ...Nature Medicine 29 (1), 258-269, 2023202
4
2023
Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective
TP Setiabudiawan, RK Reurink, PC Hill, MG Netea, R van Crevel, ...Med, 2022202
3
2022
A public health intervention package for increasing tuberculosis notifications from private practitioners in Bandung, Indonesia (INSTEP2): A cluster-randomised controlled trial …
PF Hadisoemarto, BW Lestari, K Sharples, N Afifah, L Chaidir, CC Huang, ...F1000Research 10, 27, 2021202
3
2021
BCG Vaccine Protection Against Mycobacterium tuberculosis Infection by Level of Exposure in The Gambia
N Campbell, AJ Verrall, S Donkor, JS Sutherland, PC HillThe Journal of Infectious Diseases 22 (4), 719-720, 2021202
3
2021

Referred From: https://scholar.google.com/citations?hl=en&user=S2GaSkQAAAAJ

Cited by
Citations 14702
h-index 67
i10-index 179
Recommended Journals
Open Access Journals